Why are Medicare and Medicaid shown separately instead of combined?

They come from two different CMS data sources with no shared claim identifier, so they can't be reconciled into one number without double-counting or guessing. Every table and chart on this page keeps them fully separate.

Why is there no private/commercial revenue figure?

Private and commercial payer data comes from Transparency in Coverage files, which only publish negotiated rates — not claims or utilization volume. Without a volume figure, no revenue number can be computed for any provider from that data.

What does "Rank" mean in the Competitive Analysis & Benchmarks tables?

For a given CPT/HCPCS code, it's this provider's position by claims volume among all providers billing that same code at that geography level (State, National, or Georgia for Medicaid) — rank 1 means the highest claims volume for that code.

Why is the Medicaid comparison limited to Georgia only?

Medicaid is administered per-state with no single national fee schedule, so a state or national comparison the way Medicare has one isn't available. Georgia (this provider's own state) is the only grouping that's conceptually meaningful.

Why are the numbers rounded to the nearest 10?

To avoid implying more precision than the underlying data supports at a single-provider level. Ratios are kept precise since they're a relative comparison, not a volume or dollar figure.

How current is this data?

The Medicare and Medicaid tables are both single current snapshots, not refreshed on a recurring schedule yet.

Mark Rivellese (NPI 1891798039)

Field	Value
Entity Type	Individual
Organization	Mark Rivellese
Address	1100 Johnson Ferry Rd Ne
City	Atlanta
State	GA
ZIP	30342
Taxonomy	Ophthalmology Physician
NPI Enumerated	May 23, 2005

Payer Source	Total Paid
Medicare	$2.1M
Medicaid	$0

Key Findings

This provider is an ophthalmology physician with a clear retina-focused procedural mix: the top revenue drivers are anti-VEGF and intravitreal therapy codes J0178, J2777, and J2778, plus intravitreal injection procedure 67028 and retinal imaging 92134, indicating routine administration of intravitreal biologics and supporting diagnostic imaging rather than general primary eye care. The presence of high-volume biologic administration (J0178: 1.3K claims, $873.9K revenue; J2777: 20.3K claims, $589.9K revenue; J2778: 1.7K claims, $302.9K revenue) is consistent with a practice organized around recurring injection treatments for posterior-segment retinal disease.

Revenue concentration is high: the precomputed top-3 Medicare codes by revenue (J0178, J2777, J2778) account for 82.9% of this provider's total Medicare revenue, underscoring dependence on a small set of drug injection codes for the bulk of clinical revenue within the $2.1M Medicare lifetime total. This concentration suggests business risk tied to utilization patterns or reimbursement changes for those agents.

The payer mix is effectively single-payer Medicare: lifetime Medicare revenue is $2.1M while Medicaid shows none on file, so all reported public-payer activity in the dataset is Medicare-based and there is no Medicaid billing to evaluate. Analysts should treat this profile as Medicare-dominant when modeling revenue sensitivity to Medicare policy or drug pricing shifts.

Competitive standing on the largest revenue codes is modest-to-above-average rather than market-leading: J0178 ranks #1025 of 3204 providers nationally (68th percentile; typical, unremarkable volume), J2777 ranks #514 of 2039 (75th percentile; typical, unremarkable volume), and J2778 ranks #261 of 1208 (78th percentile; typical, unremarkable volume), indicating the provider operates at a commonly observed scale for these high-cost drug administrations rather than being a national outlier. By contrast, procedural and diagnostic codes show some notable strengths — 92014 ranks in the 95th percentile and 92134 in the 97th percentile, both labeled "notably above typical national volume," which points to higher-than-average use of comprehensive exams and retinal imaging.

Operational picture: the combination of very high claim counts for drug administration (for example, J2777 with 20.3K claims) together with elevated imaging (92134, 2.1K claims) and comprehensive exam activity (92014, 969 claims) implies a practice workflow built around frequent follow-up visits, injection clinics, and point-of-care retinal imaging. Support services and scheduling capacity for regular intravitreal injections and OCT imaging are likely important to this provider's day-to-day operations.

Statistical standing of ancillary codes is mixed: several vision-service codes that contribute smaller shares of revenue nonetheless appear at or above typical national volume — for example, 67028 (1.3K claims, $130.8K revenue) ranks in the 77th percentile and 92014 is notably above typical — while many other codes such as J7312 (245 claims, $38.2K revenue) and J9035 (205 claims, $10.7K revenue) are characterized as typical or unremarkable. This pattern indicates concentrated drug revenue with a surrounding baseline of expected ancillary procedure and imaging utilization.

Tenure and potential experience signal: the provider's NPI was enumerated 2005-05-23 (~21 years ago), which suggests long-standing Medicare participation and an established referral or patient-follow-up base that would support recurring retina treatment regimens. Long tenure combined with the observed code mix is consistent with an experienced retinal practice rather than a recent entrant.

For payer strategy and competitive analysis, note both upside and vulnerability: the high dependence on a few biologic injection codes (top three = 82.9% of Medicare revenue) offers predictable revenue from recurring treatments but also concentrates risk if utilization, reimbursement, or formulary choices change; at the same time, above-typical volumes in 92014 and 92134 indicate competitive strengths in imaging and comprehensive exam throughput that could be leveraged to grow non-drug service lines.

Medicare: Complete Services Breakdown

The CPT/HCPCS codes generating the most Medicare revenue for this provider.

14 rows

CPT/HCPCS Code	Description	Claims	Avg Paid	Revenue
J0178	Injection, aflibercept, 1 mg	1,270	$690	$873.9K
J2777	Injection, faricimab‑svoa, 0.1 mg	20,340	$30	$589.9K
J2778	Injection, ranibizumab, 0.1 mg	1,690	$180	$302.9K
67028	The provider injects a medication into the vitreous chamber of the eye as an isolated procedure or a separate procedure unrelated to any other procedure being performed on the eye.	1,340	$100	$130.8K
92014	An ophthalmologist sees an established patient for a comprehensive level eye examination. Generally, a patient is considered to be "established" if the same physician, or any physician in the group…	970	$90	$87.2K
92134	The provider performs computerized diagnostic imaging of the retina in the posterior segment (back part) of the eye, interprets the data, and provides a report. The service may be on one or both eyes.	2,120	$30	$65.7K
J7312	Injection, dexamethasone, intravitreal implant, 0.1 mg	250	$160	$38.2K
92012	For this CPT code, an Ophthalmologist sees an established patient for an intermediate level eye examination. Generally, a patient is considered to be "established" if the same physician, or any…	210	$70	$14.1K
99204	The provider sees a new patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the provider…	100	$120	$11.9K
J9035	Injection, bevacizumab, 10 mg	210	$50	$10.7K

Showing 1–10 of 14

Medicare: Competitive Analysis & Benchmarks

How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 14 CPT/HCPCS codes.

View: State1 / 2

Claims Volume vs. Georgia Distribution

Mark Rivellese — 2 of 14 codes billed far more than typical (above p95)

p5–p95 (all providers)p25–p75MedianThis providerOutlier

Rank Distribution — Georgia

Full comparison — all codes billed, vs. state median

14 rows

CPT/HCPCS Code	Rank	Provider Count	Median Claims	Avg Paid	Average Revenue
J0178	27	70	970	$680	$700.6K
J2777	15	40	14,100	$30	$524.3K
J2778	11	30	1,170	$180	$286.2K
67028	19	80	720	$90	$71.9K
J7312	5	10	220	$160	$37.6K
92014	31	850	130	$80	$19.7K
92012	106	380	90	$60	$10.5K
J9035	23	70	120	$50	$10.3K
92134	19	620	70	$30	$7.1K
99204	659	7,260	30	$110	$5.1K

Showing 1–10 of 14

Related Providers

Other providers that share a Tax Identification Number (TIN) with Mark Rivellese, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Stephanie Vanderveldt	GA	Ophthalmology Physician	$4.1M	$0
Sri Krishna Mukkamala	GA	Hospitalist Physician	$3.4M	$0
Alexander Bottini	GA	Retina Specialist (Ophthalmology) Physician	$3M	$0
David Chin Yee	GA	Retina Specialist (Ophthalmology) Physician	$2.9M	$0
Gregory Lee	GA	Ophthalmology Physician	$2.9M	$6.3K
Robert Stoltz	GA	Specialist	$2.6M	$0
Hyung Cho	GA	Ophthalmology Physician	$2.5M	$0
Sean Koh	GA	Ophthalmology Physician	$2.5M	$0
Atul Sharma	GA	Ophthalmology Physician	$2.2M	$0
Rahul Komati	IL	Retina Specialist (Ophthalmology) Physician	$1.9M	$0

Nearby Providers

Other providers in the same ZIP code as Mark Rivellese, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Scottish Rite Children's Medical Center	GA	Pediatric Hematology & Oncology Physician	$0	$493.4M
Life Hope Labs LLC	GA	Clinical Medical Laboratory	$8.3M	$7.3K
The Childrens Center For Digestive Health Care LLC	GA	Pediatric Gastroenterology Physician	$0	$8.1M
Northside Emergency Associates, LLC	GA	Emergency Medicine Physician	$0	$6.1M
Atlanta Perinatal Consultants, LP	GA	Neonatal-Perinatal Medicine Physician	$0	$4.8M
Children's Orthopaedics Of Atlanta P.C.	GA	Orthopaedic Surgery Physician	$0	$2.5M
Paul Sutej	GA	Rheumatology Physician	$2.4M	$0
Childrens Care Pediatrics, PC	GA	Pediatrics Physician	$0	$1.9M
Resurgens Surgery Center LLC	GA	Ambulatory Surgical Clinic/Center	$1.7M	$0
Daniel Oh	GA	Retina Specialist (Ophthalmology) Physician	$1.7M	$0

Mark Rivellese — Billing Profile & Reimbursement Data

Sign up for Mark Rivellese — Billing Profile & Reimbursement Data policy alerts

Mark Rivellese — Billing Profile & Reimbursement Data

Sign up for Mark Rivellese — Billing Profile & Reimbursement Data policy alerts

Key Findings

Medicare: Total Revenue Breakdown by CPT/HCPCS Code

Medicare: Complete Services Breakdown

Medicare: Competitive Analysis & Benchmarks

Related Providers

Nearby Providers

Frequently Asked Questions

References